[HTML][HTML] Management of oxidative stress and other pathologies in Alzheimer's disease

M Simunkova, SH Alwasel, IM Alhazza, K Jomova… - Archives of …, 2019 - Springer
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder, characterized by
the formation, aggregation and accumulation of amyloid beta, perturbed metal (copper, iron …

Developments with multi-target drugs for Alzheimer's disease: An overview of the current discovery approaches

JF González, AR Alcántara, AL Doadrio… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Alzheimer's disease (AD), the most common type of dementia among older
adults, is a chronic neurodegenerative pathology that causes a progressive loss of cognitive …

Dihydrolipoic acid–gold nanoclusters regulate microglial polarization and have the potential to alter neurogenesis

L Xiao, F Wei, Y Zhou, GJ Anderson, DM Frazer… - Nano …, 2019 - ACS Publications
Microglia-mediated neuroinflammation is one of the most significant features in a variety of
central nervous system (CNS) disorders such as traumatic brain injury, stroke, and many …

Targeting mitochondria in Alzheimer disease: rationale and perspectives

C Lanzillotta, F Di Domenico, M Perluigi, DA Butterfield - CNS drugs, 2019 - Springer
A decline in mitochondrial function plays a key role in the aging process and increases the
incidence of age-related disorders, including Alzheimer disease (AD). Mitochondria—the …

α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review

F Seifar, M Khalili, H Khaledyan… - Nutritional …, 2019 - Taylor & Francis
Objectives: α-lipoic acid (ALA) is a natural antioxidant which acts as a cofactor of
bioenergetic mitochondrial enzymes. Along with its mitochondrial action, ALA and its …

Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review

CNS de Sousa, CMG da Silva Leite… - Metabolic brain …, 2019 - Springer
Despite the existence of many preclinical studies, scientific evidence is lacking on the
clinical use of alpha-lipoic acid (ALA) for central nervous system disorders. Therefore, we …

Targeting inflammatory pathways in Alzheimer's disease: a focus on natural products and phytomedicines

MJ Sharman, G Verdile, S Kirubakaran, C Parenti… - CNS drugs, 2019 - Springer
Studies of the brains of Alzheimer's disease (AD) patients have revealed key
neuropathological features, such as the deposition of aggregates of insoluble amyloid-β …

α-Lipoic acid prevents senescence, cell cycle arrest, and inflammatory cues in fibroblasts by inhibiting oxidative stress

M Baeeri, H Bahadar, M Rahimifard… - Pharmacological …, 2019 - Elsevier
Senescence is a process characterized by an irreversible growth arrest in cells and induced
by oxidative stress. In the current study, anti-aging potential of a well-known antioxidant, α …

Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic …

MJ Sharman, E Gyengesi, H Liang, P Chatterjee… - Neurobiology of …, 2019 - Elsevier
Increasingly, evidence is accumulating pointing at a protective role of a healthy diet at
decreasing the risk of Alzheimer's disease. To test the effectiveness of nutritional …

Effects of alpha‐lipoic acid therapy on experimentally induced apical periodontitis: a biochemical, histopathological and micro‐CT analysis

U Aksoy, G Savtekin, AÖ Şehirli… - International …, 2019 - Wiley Online Library
Aim To investigate the possible therapeutic effects of alpha‐lipoic acid (ALA) in a model of
chronic apical periodontitis in rats by analysing biochemical, histopathological and micro …